Cargando…
The Joint Vasculitis Registry in German-speaking countries (GeVas) – a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis
BACKGROUND: Vasculitides comprise a group of rare diseases which affect less than 5 in 10.000 individuals. Most types of vasculitis can become organ- and life-threatening and are characterized by chronicity, high morbidity and relapses, altogether resulting in significant morbidity and mortality. Pr...
Autores principales: | Iking-Konert, Christof, Wallmeier, Pia, Arnold, Sabrina, Adler, Sabine, de Groot, Kirsten, Hellmich, Bernhard, Hoyer, Bimba F., Holl-Ulrich, Konstanze, Ihorst, Gabriele, Kaufmann, Margit, Kötter, Ina, Müller-Ladner, Ulf, Magnus, T., Rech, Jürgen, Schubach, Fabian, Schulze-Koops, Hendrik, Venhoff, Nils, Wiech, Thorsten, Villiger, Peter, Lamprecht, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325211/ https://www.ncbi.nlm.nih.gov/pubmed/34330340 http://dx.doi.org/10.1186/s41927-021-00206-2 |
Ejemplares similares
-
Reuma.pt/vasculitis – the Portuguese vasculitis registry
por: Ponte, Cristina, et al.
Publicado: (2020) -
Granulomatous Inflammation in ANCA-Associated Vasculitis
por: Müller, Antje, et al.
Publicado: (2021) -
Imaging in Vasculitis
por: Guggenberger, Konstanze Viktoria, et al.
Publicado: (2020) -
SARS-CoV-2 & Rheuma: Konsequenzen der SARS-CoV-2-Pandemie für Patienten mit entzündlich rheumatischen Erkrankungen. Ein Vergleich der Handlungsempfehlungen rheumatologischer Fachgesellschaften und Risikobewertung verschiedener antirheumatischer Therapien
por: Leipe, J., et al.
Publicado: (2020) -
Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis
por: Kameoka, Yosuke, et al.
Publicado: (2019)